Introduction
============

Currently, radiotherapy is one of the most important treatment modalities for patients with esophageal cancer (EC), but it is associated with poor therapeutic effect. The overall 5-year survival rate for patients treated with conventional doses of radiotherapy alone is below 10%.[@b1-ott-10-177],[@b2-ott-10-177] Local recurrence is one of the main causes of treatment failure. The main reason for local failure after radiotherapy is the inability to precisely define accurate target volumes.

The majority of patients with EC are treated during free respiration. In this state, EC motion can be attributed to respiration, cardiac activity, and peristalsis.[@b3-ott-10-177] Therefore, it is necessary to investigate the methods of tumor motion to improve the accuracy of target volume delineation in the image for radiation treatment planning.

Four-dimensional CT (4DCT) has been considered as an effective tool for assessing tumor and organ motion.[@b4-ott-10-177]--[@b6-ott-10-177] One approach to define tumor motion is to contour gross target volumes (GTVs) on ten phases of 4DCT and obtain internal gross target volume (IGTV) by combining them; theoretically, this would give information about the entire tumor motion.[@b7-ott-10-177],[@b8-ott-10-177]

A free-breathing PET (FB-PET) scan is performed in multiple bed steps for 2--5 minutes; it represents a time-averaged map of the tumor position. The blurred target outline on the FB PET scan could help to define the internal target volume (ITV).[@b9-ott-10-177] Theoretically, for PET images, the high contrast between tumor and background indicates that even long acquisitions do not result in the tumor being lost in the background. Phantom studies have supported this theory,[@b10-ott-10-177],[@b11-ott-10-177] but there are no clinical data that validate it.

Considering that both FBPET and 4DCT could help to define an ITV, it seems logical to compare PET thresholds to 4DCT to determine an optimal segmentation method. Despite the fact that respiratory 4D PET-CT techniques are highly useful in target volume delineation[@b12-ott-10-177] (accurately representative of organ and lesion motion), the feasibility of implementing it in determining the GTV for EC is still unknown. 3DPET-CT, integrated with 4DCT, might be selected as an alternative. It is necessary to study the relevance between the FB 3DPET-based GTVs and 4DCT-based targets in determining target motion in radiation treatment. Ten delineation methods were used to define the best volume fit between the two different modality-based target volumes for EC.

Materials and methods
=====================

Patient selection and characteristics
-------------------------------------

Patients with pathologically proven EC scheduled to accept radiotherapy were consecutively enrolled. None of them had been treated with radiotherapy or chemotherapy before. Thirty-one patients with EC were selected between November 2012 and November 2014. The patients with maximal standardized uptake value (SUV) on PET of less than 2.0 were excluded. Totally, the data from 20 patients were available for investigation. The patient characteristics are listed in [Table 1](#t1-ott-10-177){ref-type="table"}.

CT acquisition
--------------

During the simulation, all patients were fixed in a relatively stable position using a thermoplastic mask and by placing their arms on the side of the body. For each patient, an axial enhanced 3DCT scan of the thoracic region was performed, followed by an enhanced 4DCT scan under uncoached FB conditions on a 16-slice CT scanner (Philips Brilliance Bores CT, Philips, the Netherlands) with the administration of intravenous contrast agents. A total of 100 mL of ioversol was injected intravenously, 2 mL/s for 3DCT, and 1 mL/s for 4DCT. The 3DCT and 4DCT data sets were acquired from the 20 patients on a 16-slice CT scanner (Philips Brilliance Bores CT) during FB. Three laser alignment lines were marked on the patient before CT acquisition. The 3DCT scan, in which 12 contiguous slices with a thickness of 3 mm thickness were produced per gantry rotation (1 s) and interval (1.8 s) between rotations, was acquired in sequential mode, and the 4DCT scan was acquired in helical mode with the scanning pitch between 0.09 and 0.15. The respiratory signal was recorded with the Varian real-time position management system (Varian Medical Systems, Palo Alto, CA, USA), by measuring the displacement of the infrared markers placed on the epigastric region of the patient's abdomen. GE Advantage 4D software (GE Healthcare, Waukesha, WI, USA) was used to sort the reconstructed 4DCT images into ten respiratory phases labeled as 0%--90% on the basis of triggered signal. Phase 0% denoted the maximum end inspiration and phase 50% denoted the maximum end expiration. The 4DCT images were reconstructed using a thickness of 3 mm.

PET-CT image acquisition
------------------------

On the same day as the 4DCT scan, the ^18^F-FDG-PET/CT scans of the chest were performed with an integrated PET/CT scanner (Philips Gemini TF Big Bore). Using the same immobilization devices, the patient was positioned identical to that for the 4DCT scan. Two radiation therapists were present to ensure the accuracy of the setup, assessed using a laser localizer and skin marks. All patients fasted for at least 6 hours before the PET/CT examination. All patients were injected with 7.4 MBq/kg body weight of ^18^F-FDG and then rested for approximately 1 hour in a quiet room before imaging. The 16-slice CT component was operated with an X-ray tube voltage peak of 120 kV, 90 mA, a slice thickness of 5 mm, and an interval of 4 mm and was used both for attenuation correction of PET data and for localization of ^18^F-FDG uptake in PET images. No CT contrast agent was administered. PET scanning was performed covering the same axial range for 2 minutes per bed position (total of 3--5 bed positions). Both PET and CT acquisition was performed during FB. Data were reconstructed using an ordered subset expectation maximization algorithm and attenuation correction derived from CT data. Then, the PET/CT images were transferred to MIM software (Cleveland, OH, USA).

Image registration
------------------

All the image data were transferred into MIM. An initial automatic rigid registration was performed. Because the 3DCT and 4DCT images for the same person were produced during the same imaging session, MIM would consider the images as being registered with each other. After the image data sets were coregistered with the help of the transmission CT from PET/CT, the 4DCT images will be autoregistered with the CT component of PET/CT.

PET-CT and CT target volume delineation and data acquisition
------------------------------------------------------------

The targets in our study were contoured by the same senior radiotherapist; the radiotherapist underwent a strict training and contoured the targets following the same standard: The GTVs of different phases were delineated using the same window width and window level following the standards of an esophageal wall thickness \>5 mm or an esophageal wall diameter (without gas) \>10 mm. We could not ignore the error in the intraobserver by manual contouring. Before the formal contouring, we did a test: The radiotherapist contoured the targets two times in 6 patients (2 in the upper, 2 in the middle, and 2 in the distal, randomly) 2 weeks apart; the results are listed in [Table 2](#t2-ott-10-177){ref-type="table"}. No significant differences were observed between the two times.

Therefore, our results would be less affected by the manual contouring intraobserver errors.

GTVs were manually contoured on the ten phases of the 4DCT images using mediastinal window setting (window width =400 HU, window level =40 HU). IGTV~10~ were obtained by combining GTVs contoured on ten phases of 4DCT. PET/CT-based GTVs of the primary tumor were automatically contoured by using nine different methods: SUV ≥2.0, ≥2.5, ≥3.0, ≥3.5; ≥20%, ≥25%, ≥30%, ≥35%, ≥40% of the maximum SUV~max~, and visual contouring. The methods were determined by the results of other references.[@b10-ott-10-177],[@b13-ott-10-177]--[@b16-ott-10-177] All the noncancerous regions within the GTV~PET~, including the areas overlaid by the heart, bone, and great vessels, were corrected to exclude manually with the help of the CT component of PET/CT. The target volumetric size, the centroid coordinates for PET contours, and IGTV~10~ can be determined by MIM. [Figure 1](#f1-ott-10-177){ref-type="fig"} shows an example of the GTV delineated in the text.

Target volume centroid distance
-------------------------------

Then target centroid shift in the left--right (LR), anterior--posterior (AP), and cranial--caudal (CC) directions between GTV~PET~ and IGTV~10~ was obtained as Δ*x*, Δ*y*, and Δ*z*, respectively. The centroid distance was calculated as follows: $$V = \left( {\Delta x^{2} + \Delta y^{2} + \Delta z^{2}} \right)^{1/2}$$

Volume ratio, conformity index, and degree of inclusion
-------------------------------------------------------

To compare GTV~PET~ based on PET-CT and IGTV~10~ based on 4DCT, three measures were used: volume ratio (VR), conformity index (CI), and degree of inclusion (DI). The VR is the ratio of two volumes. The conformity index of volume A and B \[CI (A, B)\] was defined as the ratio of the intersection of A with B to the union of A and B.[@b13-ott-10-177] The maximum value of CI is 1 if the two volumes are identical, and the minimum value is 0 if the volumes are completely nonoverlapping. That is, $$\text{CI} = A \cap B/A \cup B$$

The definition of DI of volume A included in volume B, \[DI (A in B)\], is the intersection between volume A and volume B divided by volume A. The formula is as follows:[@b7-ott-10-177] $$\text{DI}\left( \text{A~in~B} \right) = A \cap B/A$$

Statistical analysis
--------------------

The SPSS software package (SPSS 17.0, Chicago, IL, USA) was performed for statistical analysis. Descriptive statistics were used as appropriate. The paired sample Student's *t*-test and Wilcoxon text was used for comparison of tumor position, volumetric size, CI, and DI. Values of *P*\<0.05 were regarded as significant.

Results
=======

The variations of target centroid shift between IGTV~10~ and GTV~PET~
---------------------------------------------------------------------

[Table 3](#t3-ott-10-177){ref-type="table"} lists the target centroid shift in LR, AP, CC, and 3D directions. In CC direction, the centroid coordinates of all GTV~PET~ showed statistical significance to that of IGTV~10~ (*P*\>0.05), while the GTV~PET~ in other directions differed no significantly to that of IGTV~10~ (*P*\<0.05).

Variations in VR, CI, and DI
----------------------------

The VR, CI, and DI of GTV~PET~ to IGTV~10~ are listed in [Table 4](#t4-ott-10-177){ref-type="table"}. The best volume match for VR was observed at SUV~2.5~, SUV~20%~, or manual contouring, which achieved the optimal VR values of (0.95±0.32), (1.06±0.50), and (1.07±0.49), respectively. The best fit for CI was at (0.51±0.11), SUV2.5 (0.53±0.13), SUV~20%~ (0.53±0.12), and manual contouring (0.54±0.14). The mean DIs of GTV~PET~ in IGTV~10~ were from 0.60 to 0.90, and the mean DI of IGTV~10~ in GTV~PET~ ranged from 0.35 to 0.78. A negative correlation was observed between nine different mean SUV~max~ (2.0, 2.5, 20% mean SUV~max~=2.83, 3.0, 3.5, 25% mean SUV~max~=3.53, 30% mean SUV~max~=4.24, 35% mean SUV~max~=4.95, 40% mean SUV~max~=5.65) and the mean CI (0.51, 0.53, 0.53, 0.50, 0.46, 0.51, 0.45, 0.39, 0.33) (*t*=−0.931, *P*=0.000).

The best VR and CI of the groups of low SUV~max~, median SUV~max~, and high SUV~max~
------------------------------------------------------------------------------------

The threshold may be different between low SUV~max~, median SUV~max~, and high SUV~max~. Therefore, the 20 cases on average were divided into three groups: low SUV~max~ with the six lowest SUV~max~ (7.40, 9.13, 9.33, 9.36, 9.71, 10.41) among the cases, median SUV~max~ (11.82, 11.87, 11.96, 12.29, 13.67, 14.55, 15.32) with the seven median SUV~max~, and high SUV~max~ with the seven highest SUV~max~ (15.57, 15.98, 17.20, 17.39, 19.39, 19.85, 30.40). Finally, the best VR and CI were recalculated, and these are listed in [Table 5](#t5-ott-10-177){ref-type="table"}.

The best VR and CI of the groups of different locations
-------------------------------------------------------

The threshold may also be different between different locations. Therefore, the 20 cases on average were divided into three groups: the upper segment group (five cases), the middle segment group (eight cases), and the distal (seven cases). And the best VR and CI were recalculated, in which are listed in [Table 6](#t6-ott-10-177){ref-type="table"}.

Discussion
==========

Chang et al[@b17-ott-10-177] proved that a single static PET/CT scan had the potential to replace a 4DCT to determine the tumor ITV based on an experiment of phantom or peripheral non-small-cell lung cancer patients. In a phantom study, Okubo et al[@b10-ott-10-177] showed that the PET-based ITV approximated to but did not accurately reproduce the maximum intensity projection (MIP) ITV derived from 4DCT. These previous documents focused on the comparison of the ITV based on 4DCT and PET session images by experiments of phantom and peripheral non-small-cell lung cancer patient.[@b10-ott-10-177],[@b17-ott-10-177],[@b18-ott-10-177] This research mainly concentrated on the comparison of target volumes for primary EC delineated on PET-CT and ten phases of 4DCT.

In this study, our results suggested that the target volumes contoured at SUV~2.5~, SUV~20%~, or visual interpretation matched better with the IGTV that was combined from GTVs contoured on ten phases of 4DCT in VR, CI than other SUV threshold setting methods for all patients. A negative correlation was observed between different mean SUV~max~ and the mean CI (*P*=0.000). However, the poor CIs (0.55, 0.56, 0.57) and DIs (range: 0.65--0.77) suggested that great nonconformity between IGTV~10~ and GTV~PET~. One of the reasons is that shape and/or positional alterations between IGTV~10~ and GTV~PET~ had occurred. In CC direction, the centroid coordinates of all GTV~PET~ showed statistical significance to that of IGTV~10~ (*P*), while the GTV~PET~ in other directions differed no significantly to that of IGTV~10~. Thus, these results indicated that geographic miss would come into being and that a large part of normal tissues would be irradiated whether GTV~PET~ or IGTV~10~ was used as the treatment target volume.

Our results were consistent with some previous documents. Wang et al[@b16-ott-10-177] compared GTV determined from average 4DPET and average 4DCT, and proved that GTV~PET~ at SUV~2.5~, SUV~20%~ correlated well with GTV~CT~ in tumor length, VR, and CI, but the CIs (0.58, 0.57) were also not ideal. Callahan et al[@b19-ott-10-177] used 4DPET to create "PET-MIP" image sets and segmented PET ITVs at thresholds ranging from 20% to 40% of maximum SUV. The investigators compared these volumes to ITVs drawn by radiation oncologists on the 4DCTMIP and found good overlap between PET-MIP volumes and CT-MIP volumes, but poor overlap between FBPET volumes and CT-MIP volumes.[@b19-ott-10-177] Hanna et al's[@b18-ott-10-177] work compared ITV determined from FB-PET/CT with modified 4DCT-MIP for 16 patients with NSCLC receiving SABRT using the concordance index (equivalent to CI in our study). The mean concordance index of their study was 0.64 and 0.57 in GTVPET-CT and GTV~CT~. This indicated that the target volumes derived from FB-PET did not correspond well to those derived from 4DCT-MIP.

Limitations
===========

It should be noted that, in our research, the two limitations that existed in the research by Hanna et al could be avoided. First, considering that the change of tumor geometry or size and a potential increase in the likelihood of a mismatch between IGTV~10~ and GTV~PET~ because of the treatment or long time interval during PET-CT and 4DCT, all the patients enrolled in this study performed PET-CT and 4DCT simulation scans on the same day without any treatment. Furthermore, keeping the same body position during the two simulation in our research may reduce more setup errors and the incidence of misregistration between the two simulation scans than the study by Hanna et al[@b18-ott-10-177] in which the PET simulation was performed on a curved table top while the 4DCT simulation on a flat table top. Different from this study, in our previous study, we compared the geometrical differences among planning target volumes (PTV) defined by PET combined with 4DCT, to 3DCT, and 4DCT, respectively, and discovered that PET combined with 4DCT could affect not only the volume of the PTV but also its shape.[@b20-ott-10-177] As the esophagus does not strictly run straightly up and down, and the CTV should be constructed by GTV added additional margin of 30 mm in cranial--caudal direction and 5 mm in transversal direction, therefore, the additional margin in the cranial--caudal direction should be contoured along the wall of the esophagus. So the PTV that is formed by CTV is different from the GTV.

As we all know, it is the ratio or gradient between the background ^18^F-FDG uptake and tumor uptake that makes any method of PET-based contouring possible.[@b21-ott-10-177] The size of PET delineation changes significantly depending on its threshold value. To encompass the whole tumor motion shape, the image threshold must be decreased. As mentioned earlier, it indicated that selection of an image threshold that is too low would overestimate the true volume, leading to a risk of increased normal tissue toxicity. Moreover, the method of contouring margins around the target lesion cannot be uniform, which could be verified from different results of the best VR and CI for the groups of low SUV~max~, median SUV~max~, and high SUV~max~.

In another term, esophageal motion due to respiration is important especially for lower tumors. It would be important to note the difference in GTV on phase and the IGTV~10~ in the patients in relation to location. In this paper, the best threshold between different locations for EC tells us that the SUV might be affected significantly by tumor motion ([Table 5](#t5-ott-10-177){ref-type="table"}). Thus, although a standardized method for optimal PET delineation for RTP has not yet been established, several investigators have reported that the use of single-threshold model for delineating the GTV with PET/CT is not sufficient because of the effects of the target size, motion, and image reconstruction parameters.[@b22-ott-10-177]

Other possible explanations for the geometrical mismatch between GTV~PET~ and IGTV~10~ are as follows: 1) Despite the scans being done sequentially, with the patient in the same position throughout, the patient could have moved slightly between scans. A rigid registration might not be sufficient for lung tumors. Hence, registration error may inevitably affect the spatial position between GTV~PET~ and IGTV~10~. 2) Some of this difference may be related to differences in the patient's breathing pattern between acquiring the PET/CT and 4DCT. 3) The false-positive. Thus, at the present time, it is perhaps most appropriate to consider PET as one component of a multimodality approach to target delineation, and we agree with the previous studies that suggested that PET may help to define the presence of tumor for target volume definition purposes, but the edge of the PTV should be defined from 4DCT or conventional CT.[@b23-ott-10-177] 4) The different slice thickness for the 3D and 4D CTs (3 mm) and that of the PET-CT (5 mm) may be responsible for some of the geometrical mismatch. Further evaluation and optimization of PET as a tool for target identification are required.

Conclusion
==========

Using the methods described, ^18^F-FDG PET-CT-based target volumes did not correspond well with 4DCT-based target volumes. None of the PET-based contours had both close spatial and volumetric approximation to the 4DCT IGTV~10~ for EC.
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![An example of the contours delineated in the image sessions in transversal (**A**), sagittal (**B**), and coronal section (**C**).\
**Note:** The pink contour represents the GTV on SUV~20%~, and the green one represents IGTV~10~.\
**Abbreviations:** GTV, gross target volume; SUV, standardized uptake value.](ott-10-177Fig1){#f1-ott-10-177}

###### 

The characteristics of the patients enrolled in the study

  Patients   Sex      Age (years)   Tumor location   SUV~max~   Pathologic type   TNM stage
  ---------- -------- ------------- ---------------- ---------- ----------------- -----------
  1          Female   77            Middle           19.39      Squamous          T2N1Mx
  2          Male     69            Distal           9.33       Squamous          T3N2M0
  3          Female   57            Middle           9.71       Squamous          T2N1M0
  4          Male     74            Middle           12.29      Squamous          T3N1M0
  5          Female   66            Distal           11.82      Squamous          T1N1M0
  6          Female   74            Middle           10.41      Squamous          T2N1M0
  7          Male     53            Upper            17.39      Squamous          T2N0M0
  8          Male     71            Distal           30.46      Squamous          T3N2Mx
  9          Male     62            Distal           17.2       Squamous          T2N2M0
  10         Female   58            Middle           14.55      Squamous          T2N1M0
  11         Male     80            Middle           15.98      Squamous          T2N0Mx
  12         Male     68            Distal           15.32      Squamous          T3N2M0
  13         Male     44            Distal           9.13       Squamous          T3N1M0
  14         Male     58            Upper            13.67      Squamous          T2N1M0
  15         Male     63            Middle           7.40       Squamous          T3N0M0
  16         Female   52            Upper            19.85      Squamous          T4N1M0
  17         Male     71            Distal           15.57      Squamous          T2N1Mx
  18         Male     57            Middle           11.96      Squamous          T3N2Mx
  19         Male     44            Upper            9.36       Squamous          T3N2M0
  20         Male     65            Upper            11.87      Squamous          T2N1M0

**Note:** "x" = distant metastasis unknown.

**Abbreviation:** SUV, standardized uptake value.

###### 

The variation of intraobserver for the comparison of the GTV volume between different times (cm^3^)

  Time        Upper           Middle           Lower           Overall
  ----------- ------- ------- -------- ------- ------- ------- ------------
  First       19.22   12.32   20.28    69.44   38.07   24.11   30.57±8.52
  Second      23.51   9.93    24.35    71.07   39.77   28.33   32.83±8.59
  *P*-value   --      --      --       --      --      --      *P*=0.086

**Abbreviation:** GTV, gross target volume.

###### 

The target centroid shift between GTV~PET~ and IGTV~10~ in LR, AP, and CC directions, and 3D represents the centroid distance between GTV~PET~ and IGTV~10~ (mean ± SD, and median, mm)

  Target terms        LR                   AP                 CC                 Centroid distance
  ------------------- -------------------- ------------------ ------------------ -------------------
  SUV~2.0~            −0.39±1.99 (−0.15)   0.37±1.70 (0.45)   3.33±6.26 (1.45)   5.73±4.83 (4.06)
  SUV~2.5~            −0.65±1.99 (−0.53)   0.73±1.86 (0.50)   3.24±6.71 (2.15)   6.55±4.40 (5.63)
  SUV~3.0~            −0.63±2.20 (−0.46)   0.74±1.99 (0.40)   2.48±6.13 (1.95)   5.78±4.32 (4.43)
  SUV~3.5~            −0.58±2.26 (−0.66)   0.65±1.99 (0.45)   2.61±6.75 (1.70)   6.00±4.93 (4.10)
  SUV~20%~            −0.28±2.02 (0.05)    0.45±1.50 (0.50)   2.63±6.69 (1.70)   5.87±4.73 (4.02)
  SUV~25%~            −0.59±2.25 (−0.45)   0.69±1.90 (0.45)   3.44±6.84 (2.25)   6.54±7.74 (2.50)
  SUV~30%~            −0.81±2.36 (−1.23)   0.64±1.95 (0.35)   2.75±6.53 (2.35)   6.22±4.53 (5.10)
  SUV~35%~            −0.78±2.31 (−1.30)   0.58±2.08 (0.40)   2.41±6.53 (1.95)   6.07±4.53 (4.85)
  SUV~40%~            −0.88±2.37 (1.35)    0.56±2.25 (0.50)   2.12±6.20 (1.75)   5.91±4.26 (4.92)
  Manual contouring   −0.77±1.85 (−0.70)   0.70±2.38 (0.62)   2.66±5.60 (1.83)   5.21±4.57 (4.53)

**Abbreviations:** GTV, gross target volume; LR, left--right; AP, anterior--posterior; CC, cranial--caudal; SUV, standardized uptake value.

###### 

The VR, DI, and CI of GTV~PET~ and IGTV~10~ (mean ± SD and median)

  Parameters          VR                 DIs of GTV~PET~ and IGTV~10~   CI                 
  ------------------- ------------------ ------------------------------ ------------------ ------------------
  SUV~2.0~            1.35±0.42 (1.30)   0.78±0.14 (0.83)               0.60±0.13 (0.16)   0.51±0.11 (0.50)
  SUV~2.5~            0.95±0.32 (0.93)   0.67±0.17 (0.72)               0.73±0.11 (0.74)   0.53±0.13 (0.54)
  SUV~3.0~            0.74±0.29 (0.74)   0.58±0.20 (0.65)               0.81±0.10 (0.84)   0.50±0.15 (0.53)
  SUV~3.5~            0.62±0.28 (0.65)   0.52±0.21 (0.59)               0.86±0.09 (0.88)   0.46±0.17 (0.51)
  SUV~20%~            1.06±0.50 (0.86)   0.69±0.12 (0.68)               0.72±0.18 (0.77)   0.53±0.12 (0.55)
  SUV~25%~            0.74±0.26 (0.68)   0.58±0.13 (0.61)               0.81±0.13 (0.85)   0.51±0.12 (0.51)
  SUV~30%~            0.56±0.17 (0.57)   0.49±0.12 (0.50)               0.87±0.10 (0.90)   0.45±0.11 (0.46)
  SUV~35%~            0.45±0.13 (0.46)   0.41±0.12 (0.42)               0.90±0.08 (0.92)   0.39±0.11 (0.40)
  SUV~40%~            0.37±0.13 (0.37)   0.35±0.12 (0.34)               0.79±0.26 (0.93)   0.33±0.11 (0.33)
  Manual contouring   1.07±0.49 (1.13)   0.74±0.20 (0.82)               0.75±0.26 (0.74)   0.54±0.14 (0.58)

**Abbreviations:** GTV, gross target volume; SUV, standardized uptake value; VR, volume ratio; CI, conformity index; DI, degree of inclusion; SD, standard deviation.

###### 

The best VR and CI for low SUV~max~, median SUV~max~, and high SUV~max~ groups

  Parameters                         Low SUV~max~                         Median SUV~max~                        High SUV~max~
  ---------------------------------- ------------------------------------ -------------------------------------- -----------------------------
  The best SUV value for VR and CI   2, 25% SUV~max~, manual contouring   2.5, 20% SUV~max~, manual contouring   3.0, 3.5, manual contouring

**Abbreviation:** SUV, standardized uptake value.

###### 

The best VR and CI for upper, middle, and distal segment groups

  Parameters                         Upper                                Middle                               Distal
  ---------------------------------- ------------------------------------ ------------------------------------ ----------------------------------
  The best SUV value for VR and CI   2.5, 20% SUV~max~, manual contours   2.5, 20% SUV~max~, manual contours   2.0, 20% SUVmax, manual contours

**Abbreviations:** SUV, standardized uptake value; VR, volume ratio; CI, conformity index.
